宜明昂科生物医药技术（上海）股份有限公司（股票名称：宜明昂科-B，股票代码：01541）于2026年7月9日发布翌日披露报表，公告显示公司当日于香港联交所场内回购H股63,600股，占回购前已发行股本约0.0152%。每股价格介乎3.43港元至3.53港元，合计付出221,570港元（约22.16万港元）。本次回购完成后，公司已发行股本增至420,477,305股，库藏股增加至1,786,600股。
公司于2026年5月28日获股东大会批准可回购股份总数为43,150,769股，迄今为止已于香港联交所及其他交易所累计回购1,786,600股，占授权通过当日已发行股本总数约0.414%。公司确认相关回购事项符合法律法规及上市规则要求，公告由执行董事、联席公司秘书关梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.